Radiopharm Theranostics Reports Business UpdateUnusual WhalesJul 31, 2026 at 11:02 AMResults from a Phase 2b clinical trial of the imaging agent RAD 101 have been positive, with 93% of evaluated patients who received RAD 101 meeting the primary endpoint. This indicates a promising outcome for the study involving this agent.
